Regarding AML, there is also evidence that the increased NLRP3 expression in bone marrow mononuclear cells (BMMCs) and peripheral blood mononuclear cells (PBMCs) of newly diagnosed patients correlates with the enhanced expression of the aryl hydrocarbon receptor (AHR). This evidence concerns the gene NLRP3 and acute myeloid leukemia.